Lactobacillus: a Review

Clinical Microbiology Newsletter

Volumn 30, Issue 4, 2008, Pages 23-27

  Slover, Christine M ^a  

^a ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIOCIN; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; DAPTOMYCIN; FIBRIN; GATIFLOXACIN; LACTIC ACID; MESALAZINE; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ABSCESS; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIAL FLORA; BACTERIAL GROWTH; BACTERIAL MENINGITIS; BACTERIAL VIRULENCE; BEDTIME DOSAGE; CHORIOAMNIONITIS; CLOSTRIDIUM; COLON DIVERTICULOSIS; COMBINATION CHEMOTHERAPY; CORYNEBACTERIUM; CRITICAL ILLNESS; DENTAL CARIES; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; GASTROINTESTINAL TRACT; HUMAN; IMMUNE DEFICIENCY; INFECTIOUS DIARRHEA; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BREVIS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; MICROBIAL ACTIVITY; MONOTHERAPY; NONHUMAN; STREPTOCOCCUS; THROMBOCYTE AGGREGATION; TRAVELLER DIARRHEA; TREATMENT DURATION; TREATMENT FAILURE; URINARY TRACT; VAGINA CANDIDIASIS; VAGINITIS;

EID: 38849209963     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2008.01.006     Document Type: Article

References (52)

1. Cannon J.P., et al. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur. J. Clin. Microbiol. Infect. Dis. 24 (2005) 31-40
2. Madigan M.T., et al. Prokaryotic diversity: the bacteria. In: Madigan M.T., and Martinko J.M. (Eds). Brock: biology of microorganisms (2006), Prentice Hall, Upper Saddle River, NJ 329-418
3. Kononen E., and Wade W.G. Propionibacterium, Lactobacillus, Actinomyces, and other non-spore-forming anaerobic gram-positive rods. In: Murray P.R. (Ed). Manual of clinical microbiology (2007), ASM Press, Washington, DC 872-888
4. Appendix A. In: Summanen, et al. (Ed). Wadsworth anaerobic bacteriology manual (1993), Star Publishing Company, Belmont, CA 145
5. Aguirre M., and Collins M.D. Lactic acid bacteria and human clinical infection. J. Appl. Bacteriol. 75 (1993) 95-107
6. Sharpe M.E., Hill L.R., and Lapage S.P. Pathogenic lactobacilli. J. Med. Microbiol. 6 (1973) 281-286
7. Husni R.N., et al. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin. Infect. Dis. 25 (1997) 1048-1055
8. Holliman R.E., and Bone G.P. Vancomycin resistance of clinical isolates of lactobacilli. J. Infect. 16 (1988) 279-283
9. Abgrall S., et al. Lactobacillus casei infection in an AIDS patient. Eur. J. Clin. Microbiol. Infect. Dis. 16 (1997) 180-182
10. Chomarat M., and Espinouse D. Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime-vancomycin. Eur. J. Clin. Microbiol. Infect. Dis. 10 (1991) 44
11. Schlegel L., Lemerle S., and Geslin P. Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur. J. Clin. Microbiol. Infect. Dis. 17 (1998) 887-888
12. Harty D.W.S., et al. Pathogenic potential of lactobacilli. Int. J. Food. Microbiol. 24 (1994) 179-189
13. Naude W.D.T., et al. Endocarditis caused by Lactobacillus casei subspecies rhamnosus: a case report. S. Afr. Med. J. 73 (1988) 612-614
14. Oakey H.F., Harty D.W.S., and Know K.W. Enzyme production by lactobacilli and the potential link with infective endocarditis. J. Appl. Bacteriol. 78 (1995) 142-148
15. Sussman J.I., et al. Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and review of the literature. Rev. Infect. Dis. 8 (1986) 771-776
16. Harty D.W.S., et al. The aggregation of human platelets by Lactobacillus species. J. Gen. Microbiol. 139 (1993) 2945-2951
17. Griffiths J.K., Daly J.S., and Dodge R.A. Two cases of endocarditis due to Lactobacillus species: antimicrobial susceptibility, review and discussion of therapy. Clin. Infect. Dis. 15 (1992) 250-255
18. Kim K.S., Morrison J.O., and Bayer A.S. Deficient autolytic enzyme activity in antibiotic-tolerant lactobacilli. Infect. Immun. 36 (1982) 582-585
19. Hamilton-Miller J.M.T., and Shah S. Vancomycin susceptibility as an aid to the identification of lactobacilli. Lett. Appl. Microbiol. 26 (1998) 153-154
20. Antony S., Stratton C.W., and Dummer J.S. Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin. Infect. Dis. 26 (1996) 773-778
21. Connor J.P., and Buller R.E. Case report: Lactobacillus sepsis with pelvic abscess. Gynecol. Oncol. 54 (1994) 99-100
22. Salminen M.K., et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin. Infect. Dis. 38 (2004) 62-69
23. Rogasi P.G., et al. Lactobacillus casei pneumonia and sepsis in a patient with AIDS. Case report and review of the literature. Ann. Ital. Med. Int. 13 (1998) 180-182
24. Naaber P., et al. Translocation of indigenous microflora in an experimental model of sepsis. J. Med. Microbiol. 49 (2000) 431-439
25. Berg R.D. Translocation of enteric bacteria in health and disease. Gut-derived infectious toxic shock (GITS). Curr. Stud. Hematol. Blood Transfusion 52 (1992) 44-65
26. Salminen M.K., et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin. Infect. Dis. 35 (2002) 1155-1160
27. Horwitch C.A., et al. Lactobacillemia in three patients with AIDS. Clin. Infect. Dis. 21 (1995) 1460-1462
28. Alvarez-Olmos M.I., and Oberhelman R.A. Probiotic agents and infectious diseases: a modern perspective on traditional therapy. Clin. Infect. Dis. 32 (2001) 1567-1576
29. Salminen S., and Arvilommi H. Probiotics demonstrating efficacy in clinical settings. Clin. Infect. Dis. 32 (2001) 1577-1578
30. McFarland L.V. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med. Infect. Dis. 5 (2007) 97-105
31. Briand V., et al. Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study. Clin. Infect. Dis. 43 (2006) 1170-1175
32. Tursi A., et al. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J. Clin. Gastroenterol. 40 (2006) 312-316
33. Pant A.R., et al. Lactobacillus GG and acute diarrhea in young children in the tropics. J. Trop. Pediatr. 42 (1996) 162-165
34. Arvola T., et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 104 (1999) 1-4
35. Gawronska A., et al. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment. Pharmacol. Ther. 25 (2007) 177-184
36. Savino F., et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 119 (2007) 124-130
37. Anukam K.C., et al. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 8 (2006) 2772-2776
38. Pirotta M., et al. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial. Br. Med. J. 329 (2004) 548-552
39. McGroarty J.A. Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol. Med. Microbiol. 6 (1993) 251-264
40. Hilton E., Rindos P., and Isenberg H.D. Lactobacillus GG vaginal suppositories and vaginitis. J. Clin. Microbiol 33 (1995) 1433
41. Walker R., Buckley M., and the American Academy of Microbiology. Probiotic microbes: the scientific basis. http://www.asm.org Accessed: September 10, 2007.
42. Sablon E., Contreras B., and Vandamme E. Antimicrobial peptides of lactic acid bacteria: mode of action, genetics and biosynthesis. Adv. Biochem. Eng. Biotechnol. 68 (2000) 21-60
43. Tagg J.R., Dajani A.S., and Wannamaker L.W. Bacteriocins of gram-positive bacteria. Bacteriol. Rev. 40 (1976) 722-756
44. Reid G., et al. Is there a role for lactobacilli in prevention of urogenital and intestinal infections?. Clin. Microbiol. Rev. 3 (1990) 335-344
45. Boris S., and Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2 (2000) 543-546
46. McGroarty J.A., and Reid G. Detection of lactobacillus substance that inhibits Escherichia coli. Can. J. Microbiol. 34 (1988) 974-978
47. Eschenbach D.A., et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 27 (1989) 251-256
48. Antonio M.A.D., Rabe L.K., and Hillier S.L. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J. Infect. Dis. 192 (2005) 391-398
49. Young G., Krasner R.I., and Yudkofsky P.L. Interactions of oral strains of Candida albicans and lactobacilli. J. Bacteriol. 75 (1956) 525-529
50. Hammes W.P., and Tichaczek P.S. The potential of lactic acid bacteria for the production of safe and wholesome food. Z. Lebgensm. Unters. Forsch. 198 (1997) 193-201
51. Bernardeau M., Guguen M., and Vernoux J.P. Beneficial lactobacilli in food and feed: long-term use, biodiversity and proposals for specific and realistic safety assessments. FEMS Microbial. Rev. 30 (2006) 487-513
52. Wood G.C., et al. Lactobacillus species as a cause of ventilator associated pneumonia in a critically ill patient. Pharmacotherapy 22 (2002) 1180-1182